320 related articles for article (PubMed ID: 1984636)
1. Leucine kinetics in patients with benign disease, non-weight-losing cancer, and cancer cachexia: studies at the whole-body and tissue level and the response to nutritional support.
Shaw JH; Humberstone DA; Douglas RG; Koea J
Surgery; 1991 Jan; 109(1):37-50. PubMed ID: 1984636
[TBL] [Abstract][Full Text] [Related]
2. Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions.
Pisters PW; Pearlstone DB
Crit Rev Clin Lab Sci; 1993; 30(3):223-72. PubMed ID: 8260072
[TBL] [Abstract][Full Text] [Related]
3. Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover.
Dworzak F; Ferrari P; Gavazzi C; Maiorana C; Bozzetti F
Cancer; 1998 Jan; 82(1):42-8. PubMed ID: 9428478
[TBL] [Abstract][Full Text] [Related]
4. Energy and tissue metabolism in patients with cancer during nutritional support.
Edström S; Bennegård K; Edén E; Lundholm K
Arch Otolaryngol; 1982 Nov; 108(11):697-9. PubMed ID: 6814408
[TBL] [Abstract][Full Text] [Related]
5. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
Barber MD; Preston T; McMillan DC; Slater C; Ross JA; Fearon KC
Clin Sci (Lond); 2004 Apr; 106(4):359-64. PubMed ID: 14624668
[TBL] [Abstract][Full Text] [Related]
7. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.
Lundholm K; Daneryd P; Körner U; Hyltander A; Bosaeus I
Int J Oncol; 2004 Mar; 24(3):505-12. PubMed ID: 14767534
[TBL] [Abstract][Full Text] [Related]
8. Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects.
Koopman R; Wagenmakers AJ; Manders RJ; Zorenc AH; Senden JM; Gorselink M; Keizer HA; van Loon LJ
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E645-53. PubMed ID: 15562251
[TBL] [Abstract][Full Text] [Related]
9. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of cancer cachexia: current understanding and areas for future research.
DeWys WD
Cancer Res; 1982; 42(2 Suppl):721s-726s. PubMed ID: 7055813
[TBL] [Abstract][Full Text] [Related]
11. Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma.
O'Keefe SJ; Ogden J; Ramjee G; Rund J
Cancer Res; 1990 Feb; 50(4):1226-30. PubMed ID: 2153453
[TBL] [Abstract][Full Text] [Related]
12. The effect of total starvation and very low energy diet in lean men on kinetics of whole body protein and five hepatic secretory proteins.
Afolabi PR; Jahoor F; Jackson AA; Stubbs J; Johnstone AM; Faber P; Lobley G; Gibney E; Elia M
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1580-9. PubMed ID: 17878226
[TBL] [Abstract][Full Text] [Related]
13. Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer.
Fearon KC; Hansell DT; Preston T; Plumb JA; Davies J; Shapiro D; Shenkin A; Calman KC; Burns HJ
Cancer Res; 1988 May; 48(9):2590-5. PubMed ID: 3356019
[TBL] [Abstract][Full Text] [Related]
14. Altered amino acid kinetics in rats with progressive tumor growth.
Kawamura I; Moldawer LL; Keenan RA; Batist G; Bothe A; Bistrian BR; Blackburn GL
Cancer Res; 1982 Mar; 42(3):824-9. PubMed ID: 7059980
[TBL] [Abstract][Full Text] [Related]
15. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA
Nutr Cancer; 2001; 40(2):118-24. PubMed ID: 11962246
[TBL] [Abstract][Full Text] [Related]
16. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function.
Lundholm K; Daneryd P; Bosaeus I; Körner U; Lindholm E
Cancer; 2004 May; 100(9):1967-77. PubMed ID: 15112279
[TBL] [Abstract][Full Text] [Related]
17. Altered leucine metabolism in noncachectic sarcoma patients.
Inculet RI; Stein TP; Peacock JL; Leskiw M; Maher M; Gorschboth CM; Norton JA
Cancer Res; 1987 Sep; 47(17):4746-9. PubMed ID: 3621173
[TBL] [Abstract][Full Text] [Related]
18. The scientific rationale for optimizing nutritional support in cancer.
Skipworth RJ; Fearon KC
Eur J Gastroenterol Hepatol; 2007 May; 19(5):371-7. PubMed ID: 17413286
[TBL] [Abstract][Full Text] [Related]
19. The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia.
Cersosimo E; Pisters PW; Pesola G; Rogatko A; Vydelingum NA; Bajorunas D; Brennan MF
Surgery; 1991 Apr; 109(4):459-67. PubMed ID: 2008651
[TBL] [Abstract][Full Text] [Related]
20. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
